BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25460849)

  • 1. New technology and resources for cryptococcal research.
    Zhang N; Park YD; Williamson PR
    Fungal Genet Biol; 2015 May; 78():99-107. PubMed ID: 25460849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence in Cryptococcus species.
    Ma H; May RC
    Adv Appl Microbiol; 2009; 67():131-90. PubMed ID: 19245939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Know your enemy: how to build and vanquish a global fungal scourge.
    Wang X; Li W; Sun S; Kozubowski L; Lee SC; Feretzaki M; Heitman J
    Mycopathologia; 2012 Jun; 173(5-6):295-301. PubMed ID: 21997858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.
    Gibson JF; Johnston SA
    Fungal Genet Biol; 2015 May; 78():76-86. PubMed ID: 25498576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a singleplex PCR assay for rapid identification and differentiation of Cryptococcus neoformans var. grubii, Cryptococcus neoformans var. neoformans, Cryptococcus gattii, and hybrids.
    Feng X; Fu X; Ling B; Wang L; Liao W; Yao Z
    J Clin Microbiol; 2013 Jun; 51(6):1920-3. PubMed ID: 23536400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression of Diverse Cryptococcus Isolates during Infection of the Human Central Nervous System.
    Yu CH; Sephton-Clark P; Tenor JL; Toffaletti DL; Giamberardino C; Haverkamp M; Cuomo CA; Perfect JR
    mBio; 2021 Dec; 12(6):e0231321. PubMed ID: 34724829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen and host genetics underpinning cryptococcal disease.
    Coelho C; Farrer RA
    Adv Genet; 2020; 105():1-66. PubMed ID: 32560785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for sex in the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii.
    Campbell LT; Carter DA
    FEMS Yeast Res; 2006 Jun; 6(4):588-98. PubMed ID: 16696654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient method for homologous gene reconstitution in Cryptococcus gattii using URA5 auxotrophic marker.
    Narasipura SD; Ren P; Dyavaiah M; Auger I; Chaturvedi V; Chaturvedi S
    Mycopathologia; 2006 Dec; 162(6):401-9. PubMed ID: 17146584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research trends on pathogenic Cryptococcus species in the last 20 years: a global analysis with focus on Brazil.
    Albuquerque PC; Rodrigues ML
    Future Microbiol; 2012 Mar; 7(3):319-29. PubMed ID: 22393887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection.
    Goulart L; Rosa e Silva LK; Chiapello L; Silveira C; Crestani J; Masih D; Vainstein MH
    Med Mycol; 2010 Nov; 48(7):932-41. PubMed ID: 20302549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's not all about us: evolution and maintenance of Cryptococcus virulence requires selection outside the human host.
    Gerstein AC; Nielsen K
    Yeast; 2017 Apr; 34(4):143-154. PubMed ID: 27862271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chronological history of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice.
    Kwon-Chung KJ; Perfect JR; Levitz SM
    Mycopathologia; 2012 Jun; 173(5-6):287-93. PubMed ID: 22038679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Fluorescent Strains of Cryptococcus neoformans: a Versatile Toolbox for Studies of Host-Pathogen Interactions and Fungal Biology, Including the Viable but Nonculturable State.
    de Castro RJA; Rêgo MTAM; Brandão FS; Pérez ALA; De Marco JL; Poças-Fonseca MJ; Nichols C; Alspaugh JA; Felipe MSS; Alanio A; Bocca AL; Fernandes L
    Microbiol Spectr; 2022 Oct; 10(5):e0150422. PubMed ID: 36005449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of optimal host strain for molecular pathogenesis studies on Cryptococcus gattii.
    Chaturvedi S; Ren P; Narasipura SD; Chaturvedi V
    Mycopathologia; 2005 Oct; 160(3):207-15. PubMed ID: 16205969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horse: a potential source of Cryptococcus neoformans and Cryptococcus gattii in Egypt.
    Mohammed R; Nader SM; Hamza DA; Sabry MA
    BMC Vet Res; 2022 Jan; 18(1):17. PubMed ID: 34983525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii.
    Posteraro B; Vella A; Cogliati M; De Carolis E; Florio AR; Posteraro P; Sanguinetti M; Tortorano AM
    J Clin Microbiol; 2012 Jul; 50(7):2472-6. PubMed ID: 22573595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box.
    Kronstad JW; Attarian R; Cadieux B; Choi J; D'Souza CA; Griffiths EJ; Geddes JM; Hu G; Jung WH; Kretschmer M; Saikia S; Wang J
    Nat Rev Microbiol; 2011 Mar; 9(3):193-203. PubMed ID: 21326274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.